Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA, CMS To Begin Collaborating On Drug Safety Data Collection In 2005

Executive Summary

FDA will begin using drug safety information collected by the Centers for Medicare & Medicaid Services in 2005

You may also be interested in...



FDA Personnel Moves Signal Continuity Under Commissioner Crawford

Five top-level FDA personnel appointments implemented July 29 suggest general agency policy will likely go unchanged in the near future

FDA Personnel Moves Signal Continuity Under Commissioner Crawford

Five top-level FDA personnel appointments implemented July 29 suggest general agency policy will likely go unchanged in the near future

CMS Reimbursement Tied To Data Collection Could Speed Coverage Decisions

Medicare reimbursement that is linked to requirements for post-marketing data collection could allow for faster coverage decisions on new medical products, American Enterprise Institute Resident Fellow Scott Gottlieb said at a Biotechnology Industry Organization/Windhover conference in Washington, D.C. April 27

Related Content

Topics

UsernamePublicRestriction

Register

PS045247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel